April 23, 2020
Stanford Medicine researchers, Fitbit, and Scripps Research are launching a new effort to detect early signs of viral infection through data from smartwatches and other wearable […]
April 23, 2020
COVID-19 is proving to be a disease of uncertainty. According to a study from Italy, 43% of people with the virus have no symptoms. Amongst those […]
April 23, 2020
The federal judge presiding over the criminal trial of Elizabeth Holmes, ex-CEO of Theranos, has ruled that proceedings will be delayed until October. Due to the […]
April 23, 2020
The COVID-19 pandemic has upended the public markets, but every cloud has a silver lining and experts agree that, in this case, it’s the biotech industry. […]
April 27, 2020
PERSONAL INVESTMENT HELPS DRIVE NEW CANCER THERAPY DEVELOPMENT When Stella Vnook became CEO of Diverse Biotech Inc. in mid-2019, she welcomed the challenge of guiding the […]
May 7, 2020
Alexion will buy Portola Pharmaceuticals for $1.44B, the latest deal aimed at expanding its business beyond Soliris. Alexion is betting it can increase sales of Portola’s […]
May 14, 2020
Atul Gawande is in advanced discussions to step down as chief executive and take on a less operational role as chairman of Haven, the health-care venture […]
May 22, 2020
Private biopharma investment and fundraising has seemed unaffected by the global pandemic. US venture funding for the sector reached $5.5B in the first three months of […]
May 28, 2020
By Jim Rudman, CEO, Ashton Tweed See this article on LinkedIn. When Ed Seguine, CEO of Clinical Ink, joined the company in 2010, he saw that […]